Liquid Biopsy ctDNA Monitoring and Early Molecular Screening in...

bir ses eklendi Health

2026-10-15 09:53:44 - Translate -

Liquid Biopsy ctDNA Monitoring and Early Molecular Screening in Esophageal Cancer Management

Utilizing non-invasive circulating tumor DNA (ctDNA) tracking and advanced molecular diagnostics is modernizing post-treatment surveillance in esophageal oncology. Detailed analysis within the Esophageal Cancer Market report reveals how liquid biopsy assays detect minimal residual disease (MRD) months before anatomical recurrence appears on CT or PET scans. Serial blood monitoring allows...

0 Yorumlar 0 hisse senetleri 24 Views 0 önizleme